MedAccess welcomes rollout of G6PD testing and tafenoquine in Brazil

by MedAccess

Malaria vaccine introduction “a big step forward for global health”

by MedAccess

Implementing volume guarantees for lifesaving health products

by Evans Mburu

Evans leads on post-execution success of our guarantees. Here he explains how we help to ensure health products reach the people who need them.

MedAccess welcomes Brazilian Government’s commitment to P. vivax malaria elimination efforts

by MedAccess

Net gains against malaria: A decades-long battle with insecticide-resistant mosquitos

by Melanie Brooks

Read the story


MedAccess welcomes WHO recommendation for chlorfenapyr-pyrethroid mosquito nets

by MedAccess

Next-generation mosquito net found to be highly effective in second key study

by MedAccess

BASF and MedAccess complete shipment of 35 million Interceptor® G2 nets to fight malaria

by BASF and MedAccess

P. vivax malaria elimination efforts boosted by new agreement to expand access to G6PD testing

by MedAccess

MedAccess and BASF welcome positive trial results for next-generation mosquito net

by MedAccess


MedAccess welcomes Gavi’s decision to roll out world’s first malaria vaccine

by MedAccess

The importance of tackling resistance in mosquitos

by Laura Mundy, External Relations Associate

New financing agreement boost for malaria vaccine

by MedAccess, GSK and Gavi

Getting new malaria control technologies to communities

by Laura Mundy, External Relations Associate

Cost of next generation mosquito nets almost halved

by MedAccess

A nurse takes the blood pressure of a pregnant woman. The words 'Access Matters' overlay the image.

Subscribe to our newsletter

Receive regular updates about how our innovative finance work is making healthcare products more affordable and accessible.